Literature DB >> 23928198

Magnetic resonance spectroscopy in metabolic disorders.

Andrea Rossi1, Roberta Biancheri.   

Abstract

Magnetic resonance spectroscopy (MRS) is a powerful clinical tool for investigating the metabolic characteristics of neurologic diseases. Proton ((1)H)-MRS is the most commonly used and widely available method. In this article, a brief introduction regarding technical issues of (1)H-MRS applied to the study of metabolic diseases is followed by a description of findings in some of the most common entities in this large, heterogeneous group of neurologic disorders. The aim was to provide a focused representation of the most common applications of (1)H-MRS to metabolic disorders in a routine clinical setting.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypomyelination; Leukodystrophy; Leukoencephalopathy; MR spectroscopy; Metabolic diseases; White matter

Mesh：

Substances：

Year:  2013        PMID： 23928198     DOI： 10.1016/j.nic.2012.12.013

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN： 1052-5149            Impact factor:   2.264


  9 in total

Review 1.  Advances in pediatric neuroimaging.

Authors:  Pradeep Krishnan; Prakash Muthusami; Chris Heyn; Manohar Shroff
Journal:  Indian J Pediatr       Date:  2015-01-06       Impact factor: 1.967

Review 2.  A Japanese case of cerebellar ataxia, spastic paraparesis and deep sensory impairment associated with a novel homozygous TTC19 mutation.

Authors:  Misako Kunii; Hiroshi Doi; Yuichi Higashiyama; Chiharu Kugimoto; Naohisa Ueda; Junichi Hirata; Atsuko Tomita-Katsumoto; Mari Kashikura-Kojima; Shun Kubota; Midori Taniguchi; Kei Murayama; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Naomichi Matsumoto; Fumiaki Tanaka
Journal:  J Hum Genet       Date:  2015-02-05       Impact factor: 3.172

Review 3.  Clinical 1H MRS in childhood neurometabolic diseases-part 1: technique and age-related normal spectra.

Authors:  Matthew T Whitehead; Lillian M Lai; Stefan Blüml
Journal:  Neuroradiology       Date:  2022-02-18       Impact factor: 2.804

Review 4.  Clinical 1H MRS in childhood neurometabolic diseases - part 2: MRS signatures.

Authors:  Matthew T Whitehead; Lillian M Lai; Stefan Blüml
Journal:  Neuroradiology       Date:  2022-02-28       Impact factor: 2.804

Review 5.  [MR spectroscopy in metabolic disorders of the brain].

Authors:  U Yilmaz
Journal:  Radiologe       Date:  2017-06       Impact factor: 0.635

6.  The genotypic and phenotypic spectrum of PIGA deficiency.

Authors:  Maja Tarailo-Graovac; Graham Sinclair; Sylvia Stockler-Ipsiroglu; Margot Van Allen; Jacob Rozmus; Casper Shyr; Roberta Biancheri; Tracey Oh; Bryan Sayson; Mirafe Lafek; Colin J Ross; Wendy P Robinson; Wyeth W Wasserman; Andrea Rossi; Clara D M van Karnebeek
Journal:  Orphanet J Rare Dis       Date:  2015-02-27       Impact factor: 4.123

Review 7.  Central Nervous System Complications in Cystinosis: The Role of Neuroimaging.

Authors:  Aude Servais; Jennifer Boisgontier; Ana Saitovitch; Aurélie Hummel; Nathalie Boddaert
Journal:  Cells       Date:  2022-02-15       Impact factor: 6.600

Review 8.  Preclinical Magnetic Resonance Imaging and Spectroscopy Studies of Memory, Aging, and Cognitive Decline.

Authors:  Marcelo Febo; Thomas C Foster
Journal:  Front Aging Neurosci       Date:  2016-06-29       Impact factor: 5.750

9.  A Preliminary Study on the Diagnostic Efficacy of Proton Magnetic Resonance Spectroscopy at 3.0T in Rabbit With VX2 Liver Tumor.

Authors:  Ruikun Liao; Dan Zhang; Xiaojiao Li; Jiang Ma; Jiayi Yu; Chao Yang; Hua Xiong; Bi Zhou; Xianlong Huang; Zhuoyue Tang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.